September, 2017
Nutrition 21 Presents Studies on Velositol at ISSN, Gains GRAS Status
James Komorowski, MS, CNS, vice president of scientific and regulatory affairs at Nutrition 21, presented the results of three preclinical studies on New York-based Nutrition21’s patented amylopectin and chromium combination ingredient, Velositol, at ISSN this summer…
Nutrition21 Proudly Supports the Following Industry Associations
©2023 Nutrition21, LLC. All rights reserved.
Nitrosigine®, Velositol®, nooLVL®, Lustriva®, Chromax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC. All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,028,879; 9,119,835; 9,597,404; 9,675,702; 10,183,049; and 10,245,325.